Dystrophin constructs and methods of use thereof
CA3328987A1Undetermined Publication Date: 2025-10-30CANBRIDGE PHARMACEUTICALS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CA3328987
- Authority / Receiving Office
- CA · CA
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-04-25
- Filing Date
- 2025-04-25
- Publication Date
- 2025-10-30
Abstract
The present disclosure provides gene constructs that encode a truncated dystrophin protein. The present disclosure also provides systems and methods for delivering a truncated dystrophin protein in a subject, and methods for treating a subject having a dystrophin-associated disease or disorder, e.g., muscular dystrophy, e.g., Duchenne muscular dystrophy (DMD).
Need to check novelty before this filing date? Find Prior Art
